Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Calithera Biosciences, Inc. | 75,000 | reported | 29 Nov 2016 | tx 10+216,719−30,610 |
| ARROWHEAD PHARMACEUTICALS, INC. | 57,063 | reported | 19 Dec 2025 | tx 26+129,899−68,746 |
| Annexon, Inc. | 55,000 | reported | 05 Jun 2025 | tx 5+167,000 |
| Turnstone Biologics Corp. | 12,770 | reported | 03 Jun 2024 | tx 2+38,310 |
| Protagonist Therapeutics, Inc | 7,825 | reported | 29 May 2026 | tx 40+276,846−179,950 |
| OncoMed Pharmaceuticals Inc | 0 | reported | 23 Jul 2013 | tx 3+19,159−5,159 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 29 May 2026 | EXERCISE | Protagonist Therapeutics, Inc | 9,000 | 11.80 USD | 10b5-1 |
| 29 May 2026 | SALE | Protagonist Therapeutics, Inc | 9,000 | 99.64 USD | 10b5-1 |
| 29 May 2026 | EXERCISE | Protagonist Therapeutics, Inc | 9,000 | 0.00 USD | 10b5-1deriv |
| 06 Feb 2026 | EXERCISE | Protagonist Therapeutics, Inc | 20,000 | 8.31 USD | |
| 06 Feb 2026 | SALE | Protagonist Therapeutics, Inc | 20,000 | 83.68 USD | |
| 06 Feb 2026 | EXERCISE | Protagonist Therapeutics, Inc | 20,000 | 0.00 USD | deriv |
| 02 Jan 2026 | GRANT_AWARD | Protagonist Therapeutics, Inc | 2,695 | 0.00 USD | |
| 02 Jan 2026 | GRANT_AWARD | Protagonist Therapeutics, Inc | 3,762 | 0.00 USD | deriv |
| 19 Dec 2025 | SALE | ARROWHEAD PHARMACEUTICALS, INC. | 5,451 | 68.01 USD | |
| 19 Dec 2025 | SALE | ARROWHEAD PHARMACEUTICALS, INC. | 2,416 | 66.66 USD | |
| 19 Dec 2025 | SALE | ARROWHEAD PHARMACEUTICALS, INC. | 500 | 68.53 USD | |
| 16 Dec 2025 | GRANT_AWARD | ARROWHEAD PHARMACEUTICALS, INC. | 7,819 | 0.00 USD | |
| 10 Oct 2025 | SALE | Protagonist Therapeutics, Inc | 8,000 | 87.81 USD | |
| 10 Oct 2025 | EXERCISE | Protagonist Therapeutics, Inc | 12,000 | 6.98 USD | |
| 10 Oct 2025 | SALE | Protagonist Therapeutics, Inc | 4,000 | 69.25 USD | |
| 10 Oct 2025 | EXERCISE | Protagonist Therapeutics, Inc | 12,000 | 0.00 USD | deriv |
| 22 Sept 2025 | SALE | Protagonist Therapeutics, Inc | 4,000 | 64.25 USD | |
| 27 Aug 2025 | SALE | Protagonist Therapeutics, Inc | 4,000 | 59.25 USD | |
| 05 Jun 2025 | GRANT_AWARD | Annexon, Inc. | 55,000 | 0.00 USD | deriv |
| 17 Mar 2025 | SALE | Protagonist Therapeutics, Inc | 4,000 | 54.25 USD | |
| 02 Jan 2025 | GRANT_AWARD | Protagonist Therapeutics, Inc | 5,130 | 0.00 USD | |
| 02 Jan 2025 | GRANT_AWARD | Protagonist Therapeutics, Inc | 6,584 | 0.00 USD | deriv |
| 18 Dec 2024 | GRANT_AWARD | ARROWHEAD PHARMACEUTICALS, INC. | 16,733 | 22.99 USD | |
| 16 Dec 2024 | SALE | ARROWHEAD PHARMACEUTICALS, INC. | 3,748 | 21.90 USD | |
| 17 Dec 2024 | SALE | ARROWHEAD PHARMACEUTICALS, INC. | 3,747 | 22.04 USD |